Ecstasy ( MDMA ) and serotonin release Serotonin release contributes to the locomotor stimulant effects of 3

Ecstasy ( MDMA ) and serotonin release Serotonin release contributes to the locomotor stimulant effects of 3

Pro-social MDMA (Ecstasy)-induced oxytocin release and the serotonin 5-HT(1A) receptors A role

MDMA, serotonin 5-HT2 receptor agonists and increased dopamine release Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine

MDMA (Ecstasy) induces oxytocin release in humans Increased oxytocin concentrations and prosocial feelings in humans

Pro-social MDMA (Ecstasy)-induced oxytocin release and the serotonin 5-HT(1A) receptors A role

Ecstasy ( MDMA ) and Arginine Vasopressin Release Action of MDMA (Ecstasy) and Its Metabolites on Arginine

MDMA (Ecstasy) enhances the release of acetylcholine 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of

the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) and also, critically, its increased synaptic release . The MDMA

Furthermore, application of the serotonin uptake blocker fluoxetine, which prevents MDMA-induced serotonin release, also significantly attenuated MDMA

revealed that previous AS ODN treatment failed to alter the acute DA release induced by MDMA (10

Such interaction has not previously been described involving MDMA. Sympathomimetic-MAO inhibitor interactions can cause excessive release of endogenous

MDMA and serotonin synthesis MDMA, serotonin and dopamine Potentiation of dopamine release Haloperidol pretreatment: effects Ecstasy

Noise/heart Noradrenaline Older users Opioids/MDMA Opioid receptors/MDMA Organized crime Oxidative stress Oxytocin Oxytocin release/5-HT(1a) receptors

of events resulting in the serotonergic neurotoxicity: 1. MDMA induces an acute release of 5

and 3,4-methylenedioxymethamphetamine (MDMA), is still debated. Their main acute effect, serotonin (5-HT) release from nerve endings, involves

the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) and also, critically, its increased synaptic release . The MDMA

HT tissue content. Local perfusion of MDMA increased DA and 5-HT release but did not produce

of events resulting in the serotonergic neurotoxicity: 1. MDMA induces an acute release of 5

call him Dr. Adam because his family still isn't comfortable with the public release of his

ABSTRACT 3,4-Methylenedioxymethamphetamine (MDMA, or 'Ecstasy') is an illicit drug that stimulates the release of serotonin

Noise/heart Noradrenaline Older users Opioids/MDMA Opioid receptors/MDMA Organized crime Oxidative stress Oxytocin Oxytocin release/5-HT(1a) receptors

call him Dr. Adam because his family still isn't comfortable with the public release of his

serotonin depletion (White et al., 1996). It appears to simultaneously promote the release and block

Toxicol 2002 Oct;15(10):1242-7 ABSTRACT A transient energy impairment with resultant release and subsequent

dopamine Mesolimbic dopamine Dopaminergic damage Ecstasy and serotonin synthesis Potentiation of dopamine release Haloperidol pretreatment: effects Activation

serotonin and dopamine Ecstasy and serotonin synthesis Potentiation of dopamine release Activation of striatal

stress Locomotor effects MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release MDMA, loud noise and

MDMA and serotonin synthesis MDMA, serotonin and dopamine Potentiation of dopamine release Haloperidol pretreatment: effects Refs

MDMA and serotonin synthesis MDMA, serotonin and dopamine Potentiation of dopamine release Haloperidol pretreatment: effects Refs

and dopamine Mesolimbic dopamine Ecstasy and serotonin synthesis Potentiation of dopamine release Haloperidol pretreatment: effects Activation

antisense. In vivo microdialysis revealed that the antisense treatment attenuated MDMA-induced dopamine release in the

consequences of repeated use. MDMA is an indirect monoaminergic agonist, stimulating the release and inhibiting

tend to become extraordinarily honest. People trust each other: MDMA indirectly triggers the release of oxytocin

the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) and also, critically, its increased synaptic release . The MDMA

suppression of dorsal raphe cell firing: compared to untreated preparations, peak 5-HT release, total release and

2A) receptors are needed for MDMA ('Ecstasy')-induced hyperlocomotion and 5-HT release Serotonin 5-HT2B receptors

Ecstasy and acetylcholine MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat

and serotonin synthesis Ecstasy and the serotonin receptors Pro-social MDMA-induced oxytocin release and the

effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release by Azmitia EC, Murphy

when administered to rodents. Unlike amphetamine, which has effects mediated by the release of dopamine

septal, and hippocampal monoamines (last MDMA injection-euthanasia delay: 20 days), or electrically evoked release of serotonin

commonly associated with the drug. This feeling is due to the release of neurotransmitters

when administered to rodents. Unlike amphetamine, which has effects mediated by the release of dopamine

tend to become extraordinarily honest. People trust each other: MDMA indirectly triggers the release of oxytocin

or, added alone, as an agonist, increasing the coupling signal presumably through 5-HT release from synapses. Interestingly, the

Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a recreational drug that has been shown to release serotonin (5-HT) and

SCN) of the hypothalamus, the putative mammalian circadian clock. Since dopamine release has been implicated in

inhibitors of 5-hydroxytryptamine (5-HT) uptake and carrier-mediated 5-HT release, paroxetine and citalopram

given a mind-altering substance in a bid to release them from their terrible

and immunity MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release Ecstasy and serotonin

discussed in this study. Raves Driving safety Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

acts as an indirect agonist of serotonin (5-HT) receptors by inducing 5-HT release by a 5

and a drug of abuse. MA, MDMA, and its isomers release monoamine neurotransmitters with varying

MDMA and immunity MDMA v fenfluramine Ecstasy/MDMA and cannabis Arginine-vasopressin release Ecstasy and serotonin

of memory and prolonged reaction times. Heavy users were affected stronger than moderate users. Release of cortisol

commonly associated with the drug. This feeling is due to the release of neurotransmitters

physiological response to endogenous 5-HT has not been determined. We combined pharmacologically induced release of 5

MDMA v fenfluramine Anti-Parkinsonian effect Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

MDMA, carvedilol completely reversed established hyperthermia and significantly attenuated subsequent MDMA-induced creatine kinase release. CONCLUSION: These data show

stress Locomotor effects MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

and a drug of abuse. MA, MDMA, and its isomers release monoamine neurotransmitters with varying

and immunity MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release Ecstasy and serotonin

discussed in this study. Raves Driving safety Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

vasoconstriction MDMA and the mitochondria Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

behavioral effects of this drug of abuse could be caused by massive release and depletion

A large increase seen 1 h after MDMA probably relates to the large release of serotonin

Controversies Oxidative stress MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release MDMA, loud noise and

vasoconstriction MDMA and the mitochondria Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

are thought to be related to its potent actions to release serotonin (5-HT) and

may improve emotional regulation and decrease avoidance and 3) MDMA increases norepinephrine release and circulating

MDMA and immunity MDMA v fenfluramine Ecstasy/MDMA and cannabis Arginine-vasopressin release Ecstasy and serotonin

in vivo and stimulates locomotor activity. Previous work demonstrated that MDMA-stimulated dopamine release could be reduced by

and immunity MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release MDMA, loud noise and

following use of MDMA (ecstasy). This may relate to low 5-HT release, and so

MDMA and immunity MDMA v fenfluramine Ecstasy/MDMA and cannabis Arginine-vasopressin release Ecstasy and serotonin

drug, with persistent neurotoxic effects and high prevalence among adolescents. The massive release of 5

vasoconstriction MDMA and the mitochondria Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

stress Locomotor effects MDMA v fenfluramine Cutaneous vasoconstriction Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

vasoconstriction MDMA and the mitochondria Ecstasy/MDMA and cannabis Arginine-vasopressin release Phosphatidylinositol turnover MDMA, loud

to a lack of reliable human data. MDMA produces an acute, rapid release of brain

MDMA-induced 5-HT release is inhibited by 5-HT uptake inhibitors, but MDMA-induced dopamine release may not be altered

catalyze the process of psychotherapy. On a neurochemical level, psychedelics release the same

catalyze the process of psychotherapy. On a neurochemical level, psychedelics release the same

Noise/heart Noradrenaline Older users Opioids/MDMA Opioid receptors/MDMA Organized crime Oxidative stress Oxytocin Oxytocin release/5-HT(1a) receptors

where they act as inhibitory autoreceptors or heteroreceptors, respectively. 5-HT1B receptors inhibit the release of a

by increased reaggregate serotonin levels as well as the elevated production and release of 5

MDMA, carvedilol completely reversed established hyperthermia and significantly attenuated subsequent MDMA-induced creatine kinase release. CONCLUSION: These data show

the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) and also, critically, its increased synaptic release . The MDMA